PMID: 6397578Jan 1, 1984Paper

Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study

Journal of Neuro-oncology
H J EyreC M Mansfield

Abstract

One hundred sixteen eligible patients with metastatic cancer to the brain were randomized to receive either radiotherapy 3000 rad/10 fractions (treatment 1) or the same radiotherapy plus metronidazole 6 gm/m2 (treatment 2). One hundred eleven patients were either fully or partially evaluable. The response rates (CR + PR) and survival showed no significant differences between treatments. Treatment 1: CR + PR 24%, median survival 14 weeks, Treatment 2: CR + PR 27%, median survival 12 weeks. There were no differences observed in response rates based on primary tumor site, neurologic performance status, or extent of metastatic disease. Metronidazole therapy was associated with substantial nausea and vomiting but no neurotoxicity was observed. Oral metronidazole given every other day during radiation therapy provided no clinical benefit for patients with brain metastases compared to radiotherapy alone.

Citations

Feb 1, 1993·Journal of Neuro-oncology·W BoogerdG Baris
Jul 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·W Boogerd
Jun 14, 2005·Cancer Treatment Reviews·May N TsaoUNKNOWN Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-based Care
Jun 30, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Tulika Ranjan, Lauren E Abrey
Oct 23, 2003·Clinical Oncology : a Journal of the Royal College of Radiologists·M N TsaoUNKNOWN National Cancer Institute of Canada Workshop on Symptom Control in Radiation Oncology
Apr 14, 2011·Nature Reviews. Clinical Oncology·April F EichlerRakesh K Jain
Apr 6, 2005·BMC Cancer·May N TsaoUNKNOWN Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-based Care
Sep 19, 2008·Radiation Oncology·Andrew BaschnagelKevin Camphausen
Jan 8, 2009·Journal of Experimental & Clinical Cancer Research : CR·Gustavo Arruda VianiEduardo Jose Stefano
Jun 24, 2014·Clinical Lung Cancer·David E DawePeter M Ellis
Nov 5, 2013·Journal of Radiation Oncology·Harriet Belding EldredgeGeorge C Prendergast
Aug 2, 2008·Expert Opinion on Pharmacotherapy·Christos KosmasNikolaos Mylonakis
Feb 11, 2015·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·G NoëlF Dhermain
Nov 13, 2012·Biochimica Et Biophysica Acta·Emmanouil FokasClaus Rödel
Aug 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xuling Lin, Lisa M DeAngelis
Jul 27, 2005·Journal of Pain and Symptom Management·Edward ChowCyril Danjoux
Apr 15, 2006·Expert Review of Anticancer Therapy·Ryan H Engel, Virginia G Kaklamani
Jan 25, 2018·The Cochrane Database of Systematic Reviews·May N TsaoEdward Chow
Oct 21, 2005·Neurosurgery·Minesh P Mehta, Deepak Khuntia
Jul 1, 1986·The American Journal of Hospice Care·T D Rawlins, A Houska
Nov 22, 2013·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Justyna R SarnaA Keith W Brownell
Jul 14, 2010·Nature Reviews. Clinical Oncology·Cyrus ChargariYoulia M Kirova
Apr 20, 2012·The Cochrane Database of Systematic Reviews·May N TsaoArjun Sahgal
Aug 4, 2007·The Oncologist·April F Eichler, Jay S Loeffler
Nov 30, 2011·Current Opinion in Supportive and Palliative Care·May N TsaoMinesh P Mehta
Jan 11, 2013·Bulletin du cancer·Delphine AntoniFrançoise Mornex
Sep 13, 2018·ACS Applied Materials & Interfaces·Honglin MaoHongmei Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.